{"id":988624,"date":"2026-08-03T11:01:31","date_gmt":"2026-08-03T15:01:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/"},"modified":"2026-08-03T11:01:31","modified_gmt":"2026-08-03T15:01:31","slug":"tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/","title":{"rendered":"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Teladoc Health issued full-year 2026 revenue guidance of $2.47 billion to $2.59 billion in February 2026, then cut the low end by roughly $110 million months later — and the stock fell nearly 30%. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of TDOC shareholders. <\/i>\n <\/p>\n

\n NEW YORK<\/span>, Aug. 3, 2026<\/span> \/PRNewswire\/ — A guidance reduction of $108 million at the bottom end following last quarter’s slight uplift wiped nearly 30% of Teladoc Health (NYSE: TDOC) shareholder value after the Company lowered its full-year 2026 revenue outlook to $2.36 billion to $2.45 billion. Shareholders who lost money on TDOC are encouraged to submit their loss information here <\/a> . You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com<\/a> or by telephone at (888) SueWallSt.<\/p>\n

\n

\n \"SueWallSt.com\"\n <\/p>\n<\/p><\/div>\n

On the February 25, 2026 earnings call, Chief Executive Officer Charles Divita told investors: “We expect full-year consolidated revenue to be in the range of $2.47 billion to $2.59 billion, approximately leveled with 2025 at the midpoint.” The revised range announced with Q2 2026 results sits entirely below the previous range.<\/p>\n

Investors who purchased Teladoc Health shares and suffered a loss are encouraged to click here to learn more about the investigation<\/a> or call (888) SueWallSt.<\/p>\n

\n WHY SUEWALLST <\/b> : SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n

Frequently Asked Questions About the TDOC Investigation<\/p>\n

\n Q: What is the TDOC investigation about? <\/b>A: A securities investigation is pending concerning Teladoc Health (NYSE: TDOC) regarding potentially materially false or misleading statements about the Company’s forward revenue outlook. Shares were falling nearly 30% following Teladoc’s full-year 2026 revenue guidance cut.<\/p>\n

\n Q: Which statements are being investigated as potentially misleading?\u00a0<\/b>A: The investigation concerns whether Teladoc Health made materially false or misleading statements regarding its reported revenue figures and how those figures were characterized relative to guidance on earnings calls.<\/p>\n

\n Q: Who is eligible to participate in the TDOC investigation?<\/b>\u00a0A: Investors who purchased TDOC stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.<\/p>\n

\n Q: What do TDOC investors need to do right now?\u00a0<\/b>A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt, a brand of Levi & Korsinsky LLP, for a no-cost, no-obligation evaluation at jlevi@levikorsinsky.com<\/a> or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.<\/p>\n

\n Q: What documents do I need to participate?\u00a0<\/b>A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.<\/p>\n

\n Q: What if I already sold my TDOC shares — can I still recover losses?\u00a0<\/b>A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought TDOC and sold at a loss may still participate in the investigation.<\/p>\n

\n Q: What does it cost me to participate?<\/b>\u00a0A: There is no upfront cost. Securities investigations and any resulting actions are generally handled on a contingency basis — no retainer and no out-of-pocket costs.<\/p>\n

\n Q: Do I need to go to court or give testimony?\u00a0<\/b>A: No. Participating in the investigation does not require court appearances or depositions.<\/p>\n

CONTACT:\\<\/p>\n

Levi & Korsinsky, LLP\\<\/p>\n

Joseph E. Levi, Esq.\\<\/p>\n

33 Whitehall Street, 27th Floor\\<\/p>\n

New York, NY 10004\\<\/p>\n

\n jlevi@SueWallSt.com <\/a> \\<\/p>\n

Tel: (888) SueWallSt\\<\/p>\n

Fax: (212) 363-7171<\/p>\n

Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health-302840693.html<\/a><\/p>\n

SOURCE SueWallSt.com<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire Teladoc Health issued full-year 2026 revenue guidance of $2.47 billion to $2.59 billion in February 2026, then cut the low end by roughly $110 million months later — and the stock fell nearly 30%. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of TDOC shareholders. NEW YORK, Aug. 3, 2026 \/PRNewswire\/ — A guidance reduction of $108 million at the bottom end following last quarter’s slight uplift wiped nearly 30% of Teladoc Health (NYSE: TDOC) shareholder value after the Company lowered its full-year 2026 revenue outlook to $2.36 billion to $2.45 billion. Shareholders who lost money on TDOC are encouraged to submit their loss information here . You may also contact Joseph … <\/p>\n

Continue reading “TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-988624","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Teladoc Health issued full-year 2026 revenue guidance of $2.47 billion to $2.59 billion in February 2026, then cut the low end by roughly $110 million months later — and the stock fell nearly 30%. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of TDOC shareholders. NEW YORK, Aug. 3, 2026 \/PRNewswire\/ — A guidance reduction of $108 million at the bottom end following last quarter’s slight uplift wiped nearly 30% of Teladoc Health (NYSE: TDOC) shareholder value after the Company lowered its full-year 2026 revenue outlook to $2.36 billion to $2.45 billion. Shareholders who lost money on TDOC are encouraged to submit their loss information here . You may also contact Joseph … Continue reading "TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-03T15:01:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS1812443\/suewallst-logo-1-Logo.jpg?id=OA2820202\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health\",\"datePublished\":\"2026-08-03T15:01:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/\"},\"wordCount\":662,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1812443\\\/suewallst-logo-1-Logo.jpg?id=OA2820202\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/\",\"name\":\"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1812443\\\/suewallst-logo-1-Logo.jpg?id=OA2820202\",\"datePublished\":\"2026-08-03T15:01:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1812443\\\/suewallst-logo-1-Logo.jpg?id=OA2820202\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1812443\\\/suewallst-logo-1-Logo.jpg?id=OA2820202\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/","og_locale":"en_US","og_type":"article","og_title":"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Market Newsdesk","og_description":"PR Newswire Teladoc Health issued full-year 2026 revenue guidance of $2.47 billion to $2.59 billion in February 2026, then cut the low end by roughly $110 million months later — and the stock fell nearly 30%. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of TDOC shareholders. NEW YORK, Aug. 3, 2026 \/PRNewswire\/ — A guidance reduction of $108 million at the bottom end following last quarter’s slight uplift wiped nearly 30% of Teladoc Health (NYSE: TDOC) shareholder value after the Company lowered its full-year 2026 revenue outlook to $2.36 billion to $2.45 billion. Shareholders who lost money on TDOC are encouraged to submit their loss information here . You may also contact Joseph … Continue reading \"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-03T15:01:31+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS1812443\/suewallst-logo-1-Logo.jpg?id=OA2820202","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health","datePublished":"2026-08-03T15:01:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/"},"wordCount":662,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1812443\/suewallst-logo-1-Logo.jpg?id=OA2820202","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/","name":"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1812443\/suewallst-logo-1-Logo.jpg?id=OA2820202","datePublished":"2026-08-03T15:01:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS1812443\/suewallst-logo-1-Logo.jpg?id=OA2820202","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1812443\/suewallst-logo-1-Logo.jpg?id=OA2820202"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tdoc-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-teladoc-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/988624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=988624"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/988624\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=988624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=988624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=988624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}